A clinicopathological study of postoperative pulmonary metastasis of uterine cervical carcinomas

Journal of Obstetrics and Gynaecology Research

Volumn 25, Issue 4, 1999, Pages 245-249

  Shiromizu, Kenji ^a   Kasamatsu, Takahiro ^a   Takahashi, Michiko ^a   Kikuchi, Akihiko ^a   Yoshinari, Tsutomu ^a   Matsuzawa, Masumi ^a  

^a SAITAMA CANCER CENTER   (Japan)

Author keywords

Cervical carcinoma; Chemotherapy; Lymph node metastasis; Pulmonary metastasis; Surgical resection

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; MITOMYCIN C; VINBLASTINE;

ARTICLE; CANCER SURVIVAL; FEMALE; HUMAN; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PROGNOSIS; RELAPSE; UTERINE CERVIX CARCINOMA;

EID: 0032875065     PISSN: 13418076     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1447-0756.1999.tb01156.x     Document Type: Article

References (17)

1. Webb MJ, Symmonds RE. Site of recurrence of cervical cancer after radical hysterectomy. Am J Obstet Gynecol 1980; 138: 813-817
2. Piver MS, Chung WS. Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma. Obstet Gynecol 1975; 46: 507-510
3. Lin HH, Cheng WF, Chan KWA, Chang DY, Chen CK, Huang SC. Risk factors for recurrence in patients with stage IB, IIA, and IIB cervical carci-noma after radical hysterectomy and postoperative pelvic irradiation. Obstet Gynecol 1996; 88: 274-279
4. Fuller AF, Elliot N, Kosloff C, Lewis Jr JL. Lymph node metastases from carcinoma of the cervix, stage Ib and IIa: Implications for prognosis and treatment. Gynecol Oncol 1982; 13: 165-174
5. Ito H, Shigematsu N, Kawada T, Kubo A, Isobe K, Hara R, Yasuda S, Aruga T, Ogata H. Radiotherapy for centrally recurrent cervical cancer of the vaginal stump following hysterectomy. Gynecol Oncol 1997; 67: 154-161
6. Krebs H-B, Helmkamp BF, Sevin BU, Poliakoff SR, Nadji M, Averette HE. Recurrent cancer of the cervix following radical hysterectomy and pelvic node dissection. Obstet Gynecol 1982; 59: 422-427
7. Morrow CP. Panel report: Is pelvic radiation beneficial in the postoperative management of stage Ib squamous cell carcinoma of the uterine cervix with pelvic node metastasis treated by radical hysterectomy and pelvic lymphadenectomy. Gynecol Oncol 1980; 10: 105-120
8. Photopulos GJ, Shirley REL, Ansbacher R. Evaluation of conventional diagnostic tests for detection of recurrent carcinoma of the cervix. Am J Obstet Gynecol 1977; 129: 533-535
9. Rose PG, Barker S, Fournier L, Nelson BE, Hunter RE. Serum squamous cell carcinoma antigen levels in invasive cervical cancer: Prediction of response and recurrence. Am J Obstet Gynecol 1993; 168: 942-946
10. Ngan HYS, Cheng GTS, Cheng D, Wong LC, Ma HK. Post-treatment serial serum squamous cell carcinoma antigen (SCC) in the monitoring of squamous cell carcinoma of the cervix. Int J Gynecol Cancer 1996; 6: 115-119
11. Barta JF, Soong SJ, Hatch KD, Orr JW, Shingleton HM. Diagnosis and treatment of pulmonary metastasis from cervical carcinoma. Gynecol Oncol 1990; 38: 347-351
12. Thomford NR, Woolner LB, Clagett OT. The surgical treatment of metastatic tumors in the lungs. J Thoracic Cardiovas Surg 1965; 49: 357-363
13. Seki M, Nakagawa K, Tsuchiya S, Matsubara T, Kinoshita I, Weng S-Y, Tsichiya E. Surgical treatment of pulmonary metastases from uterine cervical cancer: Optimal method by lung tumor size. J Thorac Cardiovasc Surg 1992; 104: 876-881
14. Kumar L, Bhargava VL. Chemotherapy in recurrent and advanced cervical cancer. Gynecol Oncol 1991; 40: 107-111
15. Daly M, Cowie VJ, Davis JA, Habeshaw T, Tunor EJ, Paul J, Pyer E, Reed NS, Soukop M, Yosef H, Symonds RP. A short and intensive single-agent cisplatin regimen for recurrent carcinoma of the uterine cervix. Int J Gynecol Cancer 1996; 6: 61-67
16. Vormorken JB. The role of chemotherapy in squamous cell carcinoma of the uterine cervix: A review. Int J Gynecol Cancer 1993; 3: 129-142
17. Park RC, Thigpen JT. Chemotherapy in advanced and recurrent cervical cancer. Cancer 1993; 71: 1446-1450